EcoDrugPlus

Mast/stem Cell Growth Factor Receptor Kita

Ensembl ID : ENSONIG00000008788
Gene Symbol: LOC100706409
3 Cross references
200 Possible Orthologues:

Matrilysin

Ensembl ID : ENSONIG00000005271
Gene Symbol: LOC100708330
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSONIG00000002793
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSONIG00000011812
Gene Symbol: MMP9
1 Cross references
215 Possible Orthologues:

Matrix Metalloproteinase-14

Ensembl ID : ENSONIG00000017945
Gene Symbol: LOC100691693
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-14

Ensembl ID : ENSONIG00000015561
Gene Symbol: LOC100695964
4 Cross references
196 Possible Orthologues:

Matrix Metalloproteinase-18

Ensembl ID : ENSONIG00000037417
Gene Symbol: LOC109203849
2 Cross references
194 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSONIG00000009275
Gene Symbol: MTOR
3 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSONIG00000021393
Gene Symbol: MC1R
4 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSONIG00000020458
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melanoma Receptor Tyrosine-Protein Kinase

Ensembl ID : ENSONIG00000017327
Gene Symbol: LOC100711613
2 Cross references
215 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSONIG00000010168
Gene Symbol: MTNR1A
4 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).